News

Soleno Therapeutics To Present Corporate Update at the BIO International Convention

June 04, 2018

REDWOOD CITY, Calif. , June 04, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ:SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results

May 16, 2018

REDWOOD CITY, Calif. , May 16, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ:SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome

May 14, 2018

REDWOOD CITY, Calif. , May 14, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ:SLNO), a clinical-stage ...

Read More
Soleno – Home